Fideicomiso Irrevocable F/2061 FHipo
BNZIF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $8 | $7 | $21 | $17 |
| % Growth | 25.5% | -67.5% | 22.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $8 | $7 | $21 | $17 |
| % Margin | 100% | 100% | 100% | 99.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6 | $5 | $5 | $0 |
| SG&A Expenses | $6 | $5 | $5 | -$0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$3 | $38 | $0 |
| Operating Expenses | $6 | $2 | $43 | -$0 |
| Operating Income | $10 | $5 | -$22 | $17 |
| % Margin | 122.5% | 69.8% | -107.3% | 100.6% |
| Other Income/Exp. Net | $0 | -$7 | $0 | -$8 |
| Pre-Tax Income | $3 | $5 | $2 | $9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $3 | $5 | $3 | $9 |
| % Margin | 30% | 69.5% | 12.1% | 52.2% |
| EPS | 0.007 | 0.013 | 0.007 | 0.038 |
| % Growth | -46% | 88.1% | -82.6% | – |
| EPS Diluted | 0.007 | 0.013 | 0.007 | 0.038 |
| Weighted Avg Shares Out | 373 | 18 | 373 | 230 |
| Weighted Avg Shares Out Dil | 373 | 18 | 373 | 230 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $10 | $12 | $0 | $17 |
| % Margin | 123.2% | 178.1% | 0% | 100.8% |